What is a common treatment approach for PPHN?

• A. Extracorporeal membrane oxygenation (ECMO)
• B. Only oxygen therapy
• C. Bed rest and observation
• D. Surfactant therapy

Answer: (A)

Extracorporeal membrane oxygenation (ECMO) is a commonly utilized treatment approach for persistent pulmonary hypertension of the newborn (PPHN). This condition involves high blood pressure in the pulmonary arteries, leading to reduced blood flow to the lungs and impaired oxygenation. ECMO provides a means of oxygenating blood outside of the body while allowing the lungs to rest and recover. This approach is particularly beneficial in severe cases of PPHN when other therapies have proven ineffective, as it helps maintain adequate oxygen levels and reduces the strain on the heart and lungs.

The other treatment options listed are not typically sufficient as standalone therapies for PPHN. Oxygen therapy may be a component of treatment but often is not adequate for managing severe cases. Bed rest and observation lack the necessary intervention for a condition that can rapidly deteriorate, whereas surfactant therapy primarily addresses issues like neonatal respiratory distress syndrome rather than pulmonary hypertension. Therefore, ECMO stands out as a comprehensive and effective treatment for this serious condition, allowing clinicians to provide supportive care while addressing the underlying physiological challenges.